Beacon Investment Advisory Services, Inc. Gilead Sciences, Inc. Transaction History
Beacon Investment Advisory Services, Inc.
- $2.13 Billion
- Q1 2025
A detailed history of Beacon Investment Advisory Services, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 86,661 shares of GILD stock, worth $9.44 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
86,661
Previous 80,232
8.01%
Holding current value
$9.44 Million
Previous $7.41 Million
31.02%
% of portfolio
0.46%
Previous 0.32%
Shares
31 transactions
Others Institutions Holding GILD
# of Institutions
2,286Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.48 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.95 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.83 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $137B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...